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Abstract: To establish the methods of demonstrating early fixation of metal implants to 
bone, one side of a Cobalt-Chromium (CoCr) based alloy implant surface was seeded with 
rabbit marrow mesenchymal cells and the other side was left unseeded. The mesenchymal 
cells  were  further  cultured  in  the  presence  of  ascorbic  acid,  β-glycerophosphate  and 
dexamethasone, resulting in the appearance of osteoblasts and bone matrix on the implant 
surface. Thus, we succeeded in generating tissue-engineered bone on one side of the CoCr 
implant. The CoCr implants were then implanted in rabbit bone defects. Three weeks after 
the implantation,  evaluations  of  mechanical  test, undecalcified  histological  section  and 
electron microscope analysis were performed. Histological and electron microscope images 
of the tissue engineered surface exhibited abundant new bone formation. However, newly 
formed  bone  tissue  was  difficult  to  detect  on  the  side  without  cell  seeding.  In  the 
mechanical test, the mean values of pull-out forces were 77.15 N and 44.94 N for the 
tissue-engineered and non-cell-seeded surfaces, respectively. These findings indicate early 
bone fixation of the tissue-engineered CoCr surface just three weeks after implantation. 
OPEN ACCESS Int. J. Mol. Sci. 2012, 13  5529 
 
 
Keywords:  implant-bone interface;  cobalt chromium alloy;  marrow mesenchymal cell; 
osteogenesis; tissue engineering   
 
1. Introduction 
Initial implant fixation is critical for long term performance of prosthetic arthroplasty. Therefore, 
implants ability to provide early, stable, and osseous fixation is required to ensure success in clinical 
cases. Incomplete anchorage between the implants surface and bone might lead to aseptic loosening 
and subsequent failure in the prostheses [1]. Cobalt chromium (CoCr) based alloys have been widely 
used  for  prosthetic  arthroplasty.  Their  mechanical  properties  seem  to  be  suitable  material  for  the 
purpose  of  total  hip  and  knee  joint  arthroplasty [2,3].  Recent  reports,  however,  have  raised  some 
questions  concerning  the  osteogenic function of the  CoCr  alloy, which might  cause loosening of 
arthroplasty using this alloy [4,5]. 
We have developed a novel method to solve the problem of loosening of alumina ceramics ankle 
arthroplasty using a tissue engineering approach [6]. Mesenchymal cells residing in bone marrow can 
differentiate into osteoblasts and undergo mineralization when they are cultured in the presence of 
ascorbic acid, β-glycerophosphate and dexamethasone [7–10]. On the basis of these findings, we have 
succeeded  in  fabricating  a  tissue  engineered  alumina  ceramics  implant  with  excellent osteogenic 
function,  which  improves  bone-implant  fixation.  Specifically,  the  method  involves  culturing  the 
mesenchymal cells on the alumina ceramics implant surface prior to implantation. The culture shows 
osteogenic differentiation of the cells; i.e., appearance of osteoblasts which fabricate bone matrix on the 
alumina ceramics implant.  Previously, we reported  that tissue  engineered  alumina  ceramics  caused 
early  bone  ingrowth  in  the  rabbit  model.  In  brief,  the  osteoblast/bone  matrix  formed  on  alumina 
ceramics can show further in vivo osteogenic function resulting in a stable interface between the tissue 
engineered alumina ceramics surface and the host bone [11]. Moreover, we also reported successful 
clinical cases of the tissue engineered alumina ceramics ankle arthroplasty using mesenchymal cells 
derived from patient bone marrow. These cases showed stable interface between the tissue engineered 
ceramics surface and host bone even some years post operation [6]. 
In  the  present  study,  we  focused  on  CoCr  alloys and  hypothesized  that  this  tissue  engineering 
approach could be suitable for not only alumina ceramics implant but also CoCr based alloy implant in 
order to solve the inherent problems of this alloy such as loosening. For this purpose, we conducted the 
following  study  in  which  CoCr  alloy implants  were loaded  with  cultured mesenchymal cells and 
implanted  in  rabbit  bone.  Three  weeks  after  the  implantation,  mechanical  as well as  histological 
analyses were performed to demonstrate early fixation of the alloy to the bone. 
2. Results and Discussion 
2.1. In Vitro Experiment 
We performed a tissue engineering approach for CoCr based alloy implant in order to solve problems 
of this alloy concerning the osteogenic property. The approach utilized marrow cells, which contain Int. J. Mol. Sci. 2012, 13  5530 
 
 
mesenchymal  cells  having  osteogenic  functions,  and  consisted  of  three  steps:  (1)  Proliferation  of 
mesenchymal cells from rabbit bone marrow by culture, (2) Osteogenic differentiation of the culture 
expanded cells  resulting  in  the appearance of bone-forming osteoblasts together with  bone matrix 
formation on the CoCr alloy and (3) Implantation of the the CoCr alloy in the same rabbit. To obtain the 
mesenchymal cells for step 1, we aspirated about 2 mL of rabbit bone marrow by needle. Therefore, the 
marrow harvest was performed in a minimally-invasive manner and the 2 mL marrow was enough to 
expand the number of mesenchymal cells for the experiments. During step 2, the culture mesenchymal 
cells differentiated into bone forming osteoblasts. The osteoblasts synthesize extracellular matrix in 
which bone mineral exist. The mineral can be stained with alizarin red S (Figure 1), and we conducted 
the stain to confirm bone matrix formation [9]. As seen in Figure 1, Alizarin red S was positive on the 
cell  loaded  surface.  However,  staining  was  negative  on  the  non-cell  loaded  surface.  The  results 
confirmed  that  the  surface  of  CoCr  alloy  was  covered  with  osteoblasts  and  bone  matrix  and 
demonstrated the fabrication of tissue engineered CoCr alloy implants. 
Figure 1. Alizarin red S stain of CoCr based alloy. Alizarin red S stain of the mesenchymal 
cells loaded (right) and non-cell loaded (left) surface of the alloy after in vitro osteogenic 
culture. Red color indicating bone mineral is only seen in the right figure. 
 
2.2. Mechanical Testing 
After the in vitro culture of mesenchymal cells on the CoCr alloy, we  performed step 3.  This 
consisted of in vivo implantation, to examine whether the tissue engineered CoCr implants exhibited the 
osteogenic function resulting in tight fixation of the implants to host bone.  After creation of a bone 
defect in the rabbit tibia, we inserted the CoCr implants as described later in the methods section. The 
implantation was performed on the same rabbit from which we harvested the bone marrow. The pull-out 
test was performed on 6 tibias after 3 weeks implantation. In all cases, the implants detached from the 
non-cell loaded side. Then, the implant was again placed in the grip of the testing machine to evaluate 
pull-out force between the cell loaded implant surface and the bone on the opposite side. The mean 
values of pull-out force are shown in Figure 2. The pull-out force of the cell loaded side was greater 
than that of the non-cell loaded side. The mean values of pull-out forces were 77.15 N and 44.94 N for 
the cell loaded side and non-cell loaded side, respectively. The differences of the mean values of 
pull-out force between non-cell loaded side and cell loaded side were significant (p = 0.046) (Figure 2). 
After  the  pull-out  test  of  non-cell loaded  side,  the  bare  surface  of  the  CoCr  implants  was  seen. 
Remnants of bone tissue were found after the detachment of cell loaded side.   Int. J. Mol. Sci. 2012, 13  5531 
 
 
Figure 2. Pull-out forces of the implants after 3 weeks implantation (n = 6). The data are 
indicated by box plot. This plot is used to visually summarize and compare groups of data. 
The box plot uses the median, the approximate quartiles, and the lowest and highest data 
points to convey the level, spread, and symmetry of a distribution of data values. The 
parameters used in this figure are as follows: 50 percentiles as median, median is shown as 
a horizontal bar in the box.; 25 and 75 percentiles as a concentration indicator, 75 percentiles 
is shown as a top of the box and 25 percentiles is shown as a bottom of it; minimum and 
maximum data as a distribution range. 
 
2.3. Histological Examination and Electron Microscope Analysis 
Histological examination of the implants of the non-cell loaded surface showed a connective tissue 
layer at the interface between bone and the implant surface. However, there was no bone ingrowth into 
the spaces between the CoCr based alloy beads on the implant surface. On the other hand, the cell loaded 
surface showed new bone ingrowth into the spaces between the CoCr based alloy beads on the implant 
surface. Thus, extensive newly formed bone was detected in the tissue engineered implant surface and 
these histological findings verify the results of mechanical testing which demonstrate the tight fixation 
of the cell loaded implant surface and host bone (Figure 3).  
Electron microscope analysis was consistent with the results of histological examination. Electron 
microscope images of the cell loaded surface exhibited abundant new bone formation. However, newly 
formed bone tissue was difficult to detect on the side of the non-cell loaded surface (Figure 4). Int. J. Mol. Sci. 2012, 13  5532 
 
 
Figure  3.  Toluidine blue-stained sections of the implants after 3 weeks. The cell loaded 
surface (upper images) shows extensive new bone formation into the spaces among the CoCr 
beads  on  the  implant  surface.  The  non-cell  loaded  surface  (lower  images)  shows  only 
connective tissue layers. Right figures are magnified images of the rectangular areas in the 
left figures. 
 
Figure 4. Electron microscope images of the implants after 3 weeks. As seen in Figure 6, 
abundant new bone formation is seen on the cell loaded surface (upper figures) but not on 
non-cell  loaded  surface  (lower  figures).  Right  figures  are  magnified images  of  the 
rectangular areas in the left figures. 
 
2.4. Discussion 
Metallic biomaterials have a wide range of applications as prosthetic materials for joint arthroplasty 
in the orthopedic field. In recent years, the use of Titanium (Ti) based alloys as biomaterials have increased Int. J. Mol. Sci. 2012, 13  5533 
 
 
due to superior biocompatibility and corrosion resistance compared to other metallic alloys. The Ti alloys, 
however, have a disadvantage in wear resistance due to lower elastic modulus/hardness [12] and alumina 
ceramics are attractive as an implant material for the bearing surface of prosthetic arthroplasty due to 
their high abrasion resistance and hardness. Vickers hardness of Ti alloy is approximately 340 HV and 
that of alumina ceramics is approximately 2000 HV [13,14]. On the other hand, fracture toughness of 
the alumina ceramics (less than 4 MPa m
1/2) is poor when compared to that of metals such as CoCr alloy 
(less than 100 MPa m
1/2) [13,15] and fabrication of complex shapes of the ceramics is difficult. As to the 
Young’s modulus, the modulus of CoCr alloys (220–230 GPa) is about twice than that of Ti alloys 
(100–110 GPa) [16]. Thus, CoCr based alloys possess superior stiffness and toughness, furthermore, a 
recent method [17] significantly improved the mechanical property of CoCr alloys. Therefore, the 
alloys have been used as an alternative to Ti alloys and alumina ceramics in the orthopedics industry. 
However, several studies of CoCr alloy implantation have reported the possibility of risks to successful 
arthroplasty when using such alloys [4].   
Soluble ions such as cobalt, which is a major component of CoCr alloy implants, are known to 
promote bone resorption [18] and inhibit proliferation / mineralization of bone marrow cells [19]. The 
metal ions also stimulate inflammatory cytokines and have a cytotoxic effect on cells surrounding the 
implants  [4,20–24].  Thus,  released  metal  ions  from  the  CoCr  implants  might  disturb  local  bone 
homeostasis at the bone-implant interface, leading to bone loss and thus resulting in aseptic loosening of 
the implant. If we control the bone homeostasis to promote bone formation around the implants, the bone 
loss could be prevented. One possible way is to supply osteogenic function to the implants prior to their 
implantation, because Co ions are reported to inhibit the osteogenic differentiation capability of marrow 
mesenchymal cells [19]. We thus culture-expanded the number of mesenchymal cells from bone marrow 
and then loaded the cells on the CoCr alloys. We further cultured the cells loaded CoCr alloys in the 
presence  of  ascorbic  acid,  β-glycerophosphate  and  dexamethasone and then implanted into rabbit  
bone defects.  
As  shown  in  Figure  1,  positive  staining  for  Alizarin  red  S  on  the  CoCr  alloy  implants  with 
mesenchymal cells loading indicated the appearance of osteoblasts and bone matrix formation on the 
alloy surface [25]. Thus, we succeeded in generating thin layer of tissue engineered bone on one side of 
the CoCr alloy. The alloys were implanted with due consideration given to the differences of the 
triangular cross-sectional geometry of the tibia as described later in the methods section. After 3 weeks, 
all the implants were analyzed. In mechanical testing, the non-cell loaded sides in all the implants 
detached first even though the tibia surface area facing the implants was larger. There was a significant 
difference between the pull-out force of the non-cell loaded surface and that of the cell loaded surface 
(Figure  2).  Furthermore,  histological  and  electron  microscope  images  of  the  cell  loaded  surface 
exhibited abundant new bone formation (Figures 3,4). These findings suggest that the newly formed 
bone on the cell loaded CoCr surface interlocked the implants and, importantly, tight fixation could be 
obtained just 3 weeks after implantation. We reported that the tissue engineered bone on the ceramics 
surface well integrated to host bone [26] and also experienced good clinical cases using alumina ankle 
arthroplasty [6], therefore prolonged stable fixation between the CoCr surface and host bone could   
be expected. 
While the use of poly(methyl methacrylate) (PMMA) bone cements may show good implant fixation, 
their disadvantages have been reported. They include toxicity of PMMA [27], decreased bone stock at Int. J. Mol. Sci. 2012, 13  5534 
 
 
the time of revision, difficulty in the treatment after infection around the implants and weakening of the 
fixation over time [28]. As a result, various authors have advocated cementless fixation, especially for 
young  and  active  patients  [29,30],  and  some  retrospective  studies  have  reported  better  results  for 
cementless fixation compared to cemented [31,32]. The main disadvantage of the cementless fixation, 
however, is poor fixation in the early period after the implantation. To promote early fixation, rough 
surfaces of the implants were adopted. One type of surface is the metal-bead coated implant as used in 
the present study. However, bony ingrowth into the rough surface may take some months so the issue 
with the cementless fixation is how to obtain stable early fixation [33–35]. Therefore, the use of CoCr 
alloy  implants  is  inappropriate  for  the  purpose  of  cementless  fixation  because  they  impair  the 
osteogenesis around their implants as discussed above. In this study, loading and culturing the cells on 
the CoCr implants prior to implantation achieved stable early bone fixation. These findings suggest that 
the tissue engineered CoCr implants might be used for cementless fixation in joint arthroplasty.  
Coating the metal implants with the chemically synthetic hydroxyapatite (HA) using plasma spray 
has also been introduced in an attempt to provide early as well as long-term fixation [36]. However, 
uniform coating of HA in the rough surfaces of the prosthesis is difficult. Our tissue engineering 
approach shows the appearance of bone forming osteoblasts as well as bone matrix on the surface of 
CoCr implants. The approach needs seeding of mesenchymal cells on the rough surface of the implants. 
As the cells are suspended in a culture medium, they can easily inhabit even deep surface areas. 
Therefore, the mesenchymal cells are distributed uniformly, and further differentiate into osteoblasts 
which fabricate bone matrix. Importantly, the matrix contains low crystallized carbonate containing HA, 
therefore so called biological HA exist in the tissue engineered implants [9]. Biological HA is known to 
show greater biocompatibility compared to synthetic HA. These facts indicate that our approach enabled 
us to coat the implant surface uniformly with a viable HA layer. Moreover, active osteoblasts with 
osteogenic function are present in the implant surface. Thus, our method is unique with regard to coating 
HA concomitant with active osteoblasts on the CoCr alloy implant surface. That is to say, we can 
generate an HA coating layer with osteogenic function. 
In this paper, we described the tissue engineering approach using mesenchymal cells on metallic 
implants  intended  for  orthopedic  applications;  however  we  believe  this  approach  might  also  be 
appropriate for other applications such as maxillofacial prosthesis. Further studies are needed to provide 
evidence of suitability in other clinical applications. 
3. Materials and Methods 
3.1. Preparation of Marrow Mesenchymal Cells and Implants 
Approval from the animal experimental review board of Nara Medical University was obtained 
prior to the start of the study. Mature male Japanese white rabbits weighing about 3.0 kg were used. 
Six rabbits were anesthetized and 2 mL of bone marrow was aspirated from the humerus of each rabbit. 
The bone marrow aspirates were placed in a T-75 flask (Coster Co., Cambridge, MA) and mixed with 
15 mL of Eagle mimimum essential medium (MEM; Nacalai Tesque, Inc., Kyoto, Japan) containing 
15%  fetal  bovine  serum  (FBS; JRH  Biosciences,  Lenexa,  KS)  and  a  mixture  of  antibiotics  (100 
Unit/mL penicillin, 100 mg/mL streptomycin, and 0.25 mg/mL amphotericin B; Sigma Chemicals Co., Int. J. Mol. Sci. 2012, 13  5535 
 
 
St. Louis, MO). The primary cultures were maintained in a 5% CO2 atmosphere at 37 °C . After 2 days 
of  culture,  non-adherent  cells  were  removed  and  20  mL  of  the  culture  medium  was  added.  The 
following  medium  change  was  done  at  3  times  per  week.  Floating  cells  (red  blood  cells  and 
hematopoietic cells) were removed during these medium changes. After 2 weeks of the primary culture, 
the  number  of  adherent  cells  with  fibroblastic  shape  increased.  The  adherent  cells  were  termed 
mesenchymal cells in the present study. 
The cultured mesenchymal cells were then released with 0.25% trypsin, centrifuged at 900 rpm for 
5 min at room temperature and condensed at a cell density of 1 ×  10
6 cells/mL. Cell number was 
counted by CDA-1000 (Sysmex, Kobe, Japan). Two milliliter of the cell suspension (2 ×  10
6 cells) was 
applied on one side of an implant surface and incubated overnight, then subcultured. The subcultures 
were done on six-well plates for 2 weeks with MEM containing 15% FBS, 10
−8 M dexamethasone,   
10  mM  β-glycerophosphate,  and  0.07  mM  ascorbic  acid.  This  allowed  differentiation  of  the 
mesenchymal cells to osteoblasts and formation of bone matrix on the implant surface [7,9–11]. 
The implants used in the present study were Cobalt-Chromium (CoCr) based alloy (Japan Medical 
Materials Co., Osaka, Japan) measuring 15 ×  10 ×  2 mm. The surfaces were coated with a single layer 
of 710 to 850 µm diameter CoCr based alloy beads (Figure 5). 
Figure  5. Cobalt-Chromium (CoCr) based alloy. The surfaces were coated with a single 
layer of 710 to 850 μm diameter CoCr based alloy beads. Right figure is a magnified image 
of the rectangular area in the left figure. The size of the alloy is 15 ×  10 ×  2 mm. 
 
3.2. Implantation 
After the subculturing, the CoCr alloys were implanted under general anesthesia bilaterally in the 
tibias of the rabbits from which bone marrow had been aspirated; therefore we used autogeneic marrow 
mesenchymal cells. Using sterile surgical technique, a 2-cm longitudinal skin incision was made on the 
anteromedial aspect of the proximal metaphysis of the tibia. The fascia and periosteum were incised 
and retracted to expose the tibial cortex. Using a 2-mm electric steel dental burr, a 15 ×  10 ×  2 mm 
opening was made from the medial cortex to the lateral cortex parallel to the longitudinal axis of the 
tibial metaphysis. After irrigating the opening with saline, the CoCr alloy was implanted in the frontal 
direction, perforating the tibia, and protruding from the medial-to-lateral cortex symmetrically with 
respect to the longitudinal axis of the tibial metaphysis [37,38]. The cell loaded side was implanted 
facing the anterior surface of the tibia in the right leg, and facing the posterior surface in the left leg. 
The interface between the implant and bone was not the same on both sides due to the triangular 
cross-sectional geometry of the tibia; the anterior side had a smaller facing area than the posterior side. Int. J. Mol. Sci. 2012, 13  5536 
 
 
Therefore the CoCr alloys were implanted in opposite directions in the right and left tibias to offset 
differences in test sites (Figure 6). Three weeks after implantation, each rabbit was sacrificed, and the 
tibias with implants were extracted to evaluate the pull-out force in the mechanical test. 
Figure 6. Implantation of the CoCr alloy in rabbit tibial bone defect. Left and right figure 
are anterior-posterior and lateral view, respectively. Arrows indicate the implant which 
inserted into the bone defect. 
 
3.3. Alizarin Red S Staining   
For  the  Alizarin  Red  S  staining,  the  subcultured  cell  layers  were  washed  twice  with  PBS  (−) 
(phosphate-buffered saline without Ca
2+ and Mg
2+). After fixing with 95% ethanol (4 °C , 15 min), they 
were washed with deionized water and then 0.4 mL of Alizarin Red S (Nacalai Tesque Inc.) solution 
dissolved in the PBS (5 mg/mL) was added to the culture well. After 1 min, the wells were washed 
several times with deionized water to remove the remaining stain. 
3.4. Measurement of Pull-out Force 
Eight of the 12 limbs with implants were examined by mechanical test. Two implants were excluded 
because of loosening due to infection in one limb. Thus, tibias from 6 limbs were used for this test. The 
specimens were trimmed with the implants sandwiched above and below the tibia, and were prepared for 
the detachment test using the method of Nakamura [37]. These specimens were positioned horizontally, 
and the upper and lower bone cortex was placed in a special grip. Mechanical pull-out  force was 
evaluated under tension at a crosshead speed of 0.5 mm/min (Figure 7). First, there was detachment of 
the implant from the side with weaker bonding. Maximum pull-out force was measured at detachment of 
the implant from bone. After the first pull-out test, a second pull-out test between the CoCr implant 
which was held directly with another grip and remaining cortex bone on other side was performed. Int. J. Mol. Sci. 2012, 13  5537 
 
 
Figure  7.  Mechanical  test  (pull-out  force).  (a)  Whole  image  of  the  mechanical  test;   
(b) Left photo shows a grip for first pull-out test and right shows a grip for the second 
pull-out test. The grip for the second test was used to grasp the implant directly; (c) Image 
of  first  pull-out  test.  This  is  a  magnified  image  of  the  rectangular  area  in  Figure  a;   
(d) Image of the second pull-out test. 
 
3.5. Histological Examination and Electron Microscope Analysis 
Four  of  the  12  limbs  with  implants  were  examined  by  histological  examination  and  electron 
microscope  analysis.  These  specimens  were  fixed  with  10%  neutral  buffered  formalin,  and  then 
embedded in polyester resin (Ohken, Tokyo, Japan). The resin-embedded tissue blocks were sectioned 
into midportion perpendicularly to the long axis of the implants using a sawing machine (BS3000N, 
Exakt, Norderstedt, Germany), and ground to final thickness of about 100 μm using a microgrinding 
machine  (MG4000,  Exakt,  Norderstedt,  Germany).  The  undecalcified  sections  were  then  stained   
with toluidine blue [11]. 
(a)  (b) 
(c)  (d) 
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Each block was sectioned at the implantation site and the surface of the section was polished using 
waterproof-paper.  After  setting polished sections  in  the chamber, sections  were examined using  a 
scanning electron microscope (SEM, S-3400N, HITACHI, Japan) and SEM images were acquired. 
3.6. Statistical Analysis 
Pull-out forces for the cell-loaded and noncell-loaded sides of each implant were compared using a 
Wilcoxon test. Differences with a p-value of <0.05 were considered statistically significant. 
4. Conclusions   
We have succeeded in differentiating the mesenchymal cells into active osteoblasts concomitant 
with bone matrix formation on the CoCr based alloy implant surface using rabbit bone marrow culture. 
The culture of the mesenchymal cells on the CoCr alloy implant surface prior to implantation resulted 
in a stable interface between the implant surface and host bone just 3 weeks after implantation. The 
present findings indicate early fixation of CoCr based alloy by our tissue engineering approach, which 
might lead  to the desired solution of cementless fixation in various joint arthroplasties using CoCr  
alloy implants.  
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